Equities

Bioalpha Holdings Bhd

Bioalpha Holdings Bhd

Actions
Consumer Staples Food Producers
  • Price (MYR)0.10
  • Today's Change-0.005 / -4.76%
  • Shares traded4.80m
  • 1 Year change-9.09%
  • Beta--
Data delayed at least 15 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Bioalpha Holdings Berhad is a Malaysia-based integrated health supplement company. It is principally involved in agricultural development, research and development (R&D), manufacturing, distribution and marketing of functional food and health supplement products under Original Design Manufacturer (ODM) and Original Brand Manufacturer (OBM) basis, as well as operating a retail pharmacy chain under the brand, Constant. Its product categories include Health Food, Health Drinks, Tea Ranges, Health supplements, Beauty@NuShine, and Herbal Farming. The Company's health supplement products comprise processed herbs, formulated ingredients, functional foods as well as herbal and non-herbal supplements that offer a variety of health benefits, including general health maintenance, improving blood circulation, enhancing vitality and general well-being. All of its health supplement products are halal-certified and are sold in Malaysia with Indonesia and China as export markets.

  • Revenue in MYR (TTM)46.08m
  • Net income in MYR-38.55m
  • Incorporated2011
  • Employees--
  • Location
    Bioalpha Holdings BhdNo. 10, Jalan P/9A, Seksyen 13BANDAR BARU BANGI 43650MalaysiaMYS
  • Phone+60 389222286
  • Fax+60 389222287
  • Websitehttp://bioa.com.my/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shenzhen Neptunus Intrlng Bi tchnq CoLtd693.11m15.70m146.65m1.44k9.340.24814.680.21160.01550.01550.68530.58450.74373.036.51796,388.601.013.461.575.1341.8149.141.364.291.95--0.08110.007.924.19-55.60-12.89-11.10--
Bioalpha Holdings Bhd46.08m-38.55m147.68m----1.12--3.20-0.0275-0.02750.03380.09340.2486.205.52---21.57-12.76-24.65-13.77-0.50137.95-86.99-44.601.26-31.340.0949--28.74-8.0419.41---39.39--
Inoviq Ltd2.37m-20.51m150.76m85.00--2.86--63.67-0.0708-0.07080.00820.1820.03392.100.873---29.33-47.68-32.18-50.7695.07---866.27-2,527.824.93--0.0332--119.59153.3150.71------
DOD Biotech PCL87.89m2.62m151.77m425.0065.431.1112.421.730.03970.01051.512.350.49353.349.00--1.523.551.954.4938.7741.703.076.660.78347.100.1351--26.250.3514105.89-41.91-13.87--
Cynata Therapeutics Ltd1.37m-42.99m152.81m0.00--3.95--111.18-0.0873-0.08730.00270.06830.0257--4.26---80.33-38.07-87.15-41.10-----3,127.93-513.73----0.00---94.9619.81-162.20------
Data as of May 16 2024. Currency figures normalised to Bioalpha Holdings Bhd's reporting currency: Malaysian Ringgit MYR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.